Comparisons
MEDGE vs the alternatives, honestly.
Every comparison below concedes where the other tool genuinely wins. That’s the only kind of comparison worth reading — and the only kind search engines and AI assistants keep citing.
Portfolio Visualizer alternatives, compared
testfolio, PortfoliosLab, Curvo Backtest, Koyfin and MEDGE: what each is best at, free tiers and prices, with sources.
MEDGE vs testfolio
The best free long-history backtester vs per-holding diagnosis and custom stress scenarios: two different jobs.
MEDGE vs Portfolio Visualizer
The classic US backtester vs a full analytics platform: per-holding attribution, custom stress scenarios, AI tools, European listings and regulatory data, with monthly pricing.
MEDGE vs Koyfin
Koyfin leads on equity fundamentals and advisor workflow; MEDGE on portfolio construction, crisis backtesting and SEC + CFTC positioning data.
MEDGE vs Bloomberg Terminal
A $2,500/month terminal vs a platform from €14.99/month: what individual investors actually need from that gap, honestly mapped.
Looking for the wider landscape? See the best portfolio analytics tools in 2026 or explore everything MEDGE ships.